chronic central serous chorioretinopathy. Disease of the eye and adnexa
Conditions
Interventions
In the operating room, under local anesthesia, and MAC and sterile condition by using 10% & 5% Betadine for periorbital and culdesac area and prep & drape and insertion of speculum and after 0.1 c
Treatment - Drugs
Sponsors
Guilan Universoty of Medical Sciences, Pro-vice-chancellor for resea
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : 1- patient by Acute Central Serous Chorioretinopathy for more than 4-months. 2- Comformation of The Chronic Central Serous Chorioretinopathy byOcular Coherent Tomography(OCT) and Fluorescien Angiography (FFA) . 3- comfirmation of the Diseasis by Supervisor of Study. Exclusion criteria: 1- Chronic Central Serous Chorioretinopathy more than 2 years. 2- History of Treatment by any type of Laser. 3-History of Thromboambolic Diseasis Like Myocardial Infarction and Cerebro Vascular accident. 4- History of Treatment by Intravitreal Avastin during 2 months ago. 5- any sistemic Diseasis that need Oral Corticosteroid Thrapy. 6- un - Controled Glaucoma 7- Pregnancy 8- Lack of agreement by Patient for periodic Follow up during study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vision Improvement. Timepoint: every 6 to 8 weeks untill 6 month. Method of measurement: Snelen Chart.;Anatomical Improvement. Timepoint: every 6 to 8 weeks untill 6 month. Method of measurement: Clinical exam and OCT. | — |
Secondary
| Measure | Time frame |
|---|---|
| Centeral thickness of retin. Timepoint: per 6-8 weeks till 6 month. Method of measurement: with OCT.If in the first examination( by OCT) after weeks 6 to 8 ,at least 10 % reduction in the central macular thickness occur,the patient will be periodically follow,if not ,the patient will be omitted. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohammad Rasoul Sabouri
Guilan university of Medical Sciences
Outcome results
None listed